Skip to content

Author

K. Merchant

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Reproducible cerebrospinal fluid proteomic signatures across early neuronal α-synuclein disease stages in PPMI

Parkinson's disease (PD) begins years before motor onset. Biomarkers are needed to detect early disease, stratify risk, and monitor progression. Through proximity extension assay profiling of the cerebrospinal fluid (CSF) proteome, we investigated early neuronal a-synuclein disease (NSD) in independent cohorts (discove...

S. Weber, Y. Zaplatnikov, Y. Kyriachenko et al. · 0 citations
Review Open access Oct 2026

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations

Parkinson's disease (PD) is a growing public health problem and biologically targeted therapeutics (BTTs) that slow disease progression are urgently needed. However, the development of effective BTTs is challenging as PD is a clinically defined syndrome with pathobiological heterogeneity and the pathobiological process...

R. Schneider, G. Skibinski, B. Fiske et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.